论文部分内容阅读
本文对使用重组α-2a干扰素治疗癌症病人前30分钟口服消炎病预防不良反应进行临床观察.并与传统方法,即待出现不良反应时肌肉注射安痛定进行了疗效比较.通过32例病人的观察结果显示、治疗前服用消炎痛控制干扰素不良反应的疗效明显优于传统方法.其降温及临床效果与传统方法相比较、均有显著性差异(P<0.01).
This article on the use of recombinant interferon α-2a treatment of cancer patients 30 minutes before oral anti-inflammatory disease prevention of adverse reactions were observed and compared with the traditional method, that is, adverse reactions when the intramuscular injection of analgesic compared the efficacy of 32 patients The results showed that the pretreatment of indomethacin to control adverse reactions of interferon significantly better than the traditional method.The cooling and clinical effects compared with the traditional methods were significantly different (P <0.01).